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ABSTRACT
Kidney ischemia/reperfusion injury (I/R) is the most frequent cause of acute kidney injury (AKI). It had
been reported that epithelial and endothelial injuries occurred during kidney I/R injury. Heparanase is an
enzyme that degrades glycocalyx and contributes to I/R injury in the heart and liver. This study is to elucidate
the association between heparanase expression and cell injuries in kidney I/R injury. We performed kidney
I/R injury model in mice using renal pedicle clamping for 30 minutes and sacrificed the mice in day 1 (n=6)
after operation. Sham-operation procedure (SO, n=5) was used as control. PAS staining was used to quantify
tubular injury score. Serum creatinine was measured from orbital venous. Heparanase expression was quantified
using western blot and real-time PCR. Heparanase localization and endothelial injury were shown by
immunostaining of heparanase and double glycocalyx-von Willebrand factor. Kidney I/R induced an increase
of serum creatinine level that was accompanied by elevation of tubular injury score and glycocalyx damage.
Glycocalyx damage was identified using immunofluorescent staining that revealed a disruption of glycocalyx
or lectin layer in the endothelial cells of intra-renal artery. This finding was associated with significant elevation
of heparanase mRNA and protein level expression. We found that heparanase was expressed in the renal
epithelial and interstitial cells. In conclusion, heparanase may induce endothelial and epithelial injury in the
kidney I/R episode. Using heparanase expression as a early marker of AKI may possibly promising.
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INTRODUCTION
Acute Kidney Injury (AKI) is the most common cause of mortality in clinical setting, espe-
cially in Intensive Care Unit (ICU) and elderly (Schrier et al., 20041). Kidney Ischemia-
Reperfusion (I/R) injury is the most frequent cause of AKIdue to lack of oxygen supply to
kidney, and 30-40% of this case lead to chronic kidney diseases (CKD) (Bonventre & Yang,
2011). Epithelial cell injury plays a crucial role in the AKI, and it is worsen by endothelial cell
injury. Endothelial cell injury induces prolongation of epithelial injury (Molitoris et al., 2002).
Endothelial cell injury that occurs in the extension phase of kidney I/R leads to epithelial
injury and inflammation (Molitoris & Sutton, 2004; Sutton et al., 2002). Endothelial cell injury
includes morphological changing and actin protein changing (Sutton et al., 2003). Previous
result showed swelling of endothelial cells, disruption of 2 endothelial cell attachment and
endothelial cell membrane changing occurred during I/R injury (Brodsky et al., 2002). Hipoxic
condition in the heart and liver caused disruption of glycocalyx, an endothelial surface layer
that consist of lectin and proteoglycan (Beresewicz et al., 1998). In CKD, disruption and
damage of glycocalyx had been reported in albuminuria (Salmon & Satchell, 2012), and
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adryamicin induced nephropathy (Kramer et al., 2006).
Glycocalyx is composed of glycosaminoglycan (GAG) component that consists of
heparansulphate (HS) and chondroitin sulphate. Heparan sulphate (HS) is the main compo-
nent of GAG that arranges 40-50% of glycocalyx (Mulivor & Lipowsky, 2004). In this study, we
want to elucidate the early event of glycocalyx disruption and the expression of heparanase
in the kidney I/R condition that may associates with eNOS expression. Heparanase is an
endoglycosidase enzyme that functions to cleaveheparansulphate (HS). Heparanase also
may provide a property for the early marker of AKI.
MATERIALS AND METHODS
Animal Experiment and Kidney Ischemic Reperfusion Injury Model in Black-six
We performed kidney ischemic/reperfusion injury model (I/R) in mice, male blacksix
background, 3-4 months old, 30 grams. The mice were housed in 12-hr light and dark cycle
with free access of water and chow. Four-month old male mice (each n=8) littermates were
subjected to kidney Ischemic Reperfusion Injury (IRI) model. Experiments were conducted
by following established guideline for animal cares of Gadjah Mada University. The surgical
preparation and operation used based on previously described methods (Wu et al., 2007).
Briefly, mice were anesthetized using inhalational isofluran (Merck). Abdomen was opened
and both renal pedicles were clamped using non-traumatic microaneurysm clamps for 30
minutes. Mice were placed in 370 heating pad during ischemic period. After removal of
clamp, abdomen was closed. SO mice (n=5) underwent similar procedure except for renal
pedicles clamping. We sacrificed the mice in day1 after operation to examine the extension
phase of IRI. Blood was collected from Scleral Venous and kidney tissues were divided into
snap frozen for RNA and protein examinations, embedded in OCT compound and fixed in
4% PFA for paraffin.
Kidney Function Assessment
Serum creatinin was measured in the Clinical Pathology Department of Medical Faculty
Gadjah Mada University.
Histological analysis
Four-mm paraffin sections were de-paraffinized, heated in Citrate Buffer (except for ET-
1 antibody staining) and stained for Periodic Acid Schiff to evaluate tubular injury and
immunostaining. Immunohistochemical stainings were done for anti-Heparanase antibody 3
(Abcam). Sections were de-paraffinized, and then incubated in 3% H2O2. Antibodies were
incubated for overnight. Secondary antibody incubation was done for 1 hour using Anti Rab-
bit Dako Envision System HRP labeled Polymer. Double immunofluorescencestainings were
done for von-Willebrand (DAKO) and Wheat Germ Aglutinin (WGA)-AF 488 conjugated
(Invitrogen).
Tubular Injury Score
Tubular injury was scored based on PAS staining. Scoring was done with grading tubu-
lar injury, epithelial cell apoptosis, intra-luminal cash and brush border loss in 15 randomly
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chosen, non-overlapping fields (_200 magnification). The lesions were graded on a scale
from 0 to 4: 0 = normal; 1 = mild, involving less than 25% of the cortex; 2 = moderate, involv-
ing 25 to 50% of the cortex; 3 = severe, involving 50 to 75% of the cortex; and 4 = extensive
damage, involving more than 75% of the cortex (Inazaki et al., 2004).
Real-time PCR
RNA was isolated from kidney tissue using Trizol (Invitrogen). cDNA was synthesized
using ReverTra (TOYOBO Co;Ltd, TRT-101x10). Quantitative real-time PCR was performed
using a Thunder bird SYBR® qRCR Mix (TOYOBO Co;Ltd, QPS-201x5) on an ABI 7500 RT
thermocycler, and an ABI 7500 RT PCR System.
Western blotting
Proteins extracted from kidney tissues were separated on SDS-PAGE, transferred to a
polyvinylidene fluoride (PVDF) transfer membrane, and probed with E-cadherin polyclonal
antibody (ABCAM),eNOS (BD Pharmingen), SOD2 (Santa Cruz), ETAR (Santa Cruz), PKC
(Santa Cruz) and GAPDH antibody (Invitrogen). Proteins were visualized using an ECL Plus
WB detection system (Amersham-GE Healthcare). Blots were quantified by densitometry
using LSI.
Hypoxic endothelial cells in in-vitro experiment
We induced hypoxic condition for 30 minutes in the MS-1 endothelial cells culture using
hypoxic bag. Briefly, MS-1 cells were cultured in the 10 cm dish. Hypoxic bags with oxygen
absorbent were prepared and waited to reach 0% oxygen content. Then, we put the dish in
the hypoxic bag for 30 minute. After that, we extracted RNA using Trizol and quantified pre-
pro-ET1, heparanase, endothelial Nitrite Oxide Synthase (eNOS) and ICAM-1.
RESULTS AND DISCUSSION
Increase of kidney injury and tubular injury after Ischemic-Reperfusion Episode
Serum creatinine level increased dramatically during 24 hour after kidney I/R injury (Fig.
1A). It demonstrated rapid disruption of kidney tubular epithelial cells occurred due to is-
chemic effect. Rapid elevation of creatinine level was followed by injury in tubular system
with apoptosis of epithelial cells. Kidney I/R injury caused an increase of kidney injury and
tubular injury score in cortex (Fig. 1 B).
Glycocalyx disruption in intra-renal artery and reduction of eNOS expression
We observed endothelial surface layer or glycocalyx in endothelial cell of intra-renal
arteries using WGA and von-Willebrand Factor (endothelial cell marker). We found that
kidney I/R induced disruption of glycocalyx as shown by un-complete staining of WGA in
endothelial layer of intra-renal arteries (Fig.2A) after kidney I/R injury. However, we did not
find the disruption of endothelial cell in these arteries. This finding might associated with
reduction of eNOS expression, as shown in Figure 2B.
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Figure1. Creatinine serum level and tubular injury score in day 1 after kidney I/R (A) Creatinine
serum level in day 1 after kidney I/R injury. Blood was taken from orbital venous from
mice with kidney I/R injury (each n=5) and SO (n=4) (B-C) Representative picutures of
PAS staining and tubular injury score quantification (200x magnification, 12-15 field each
samples, n=5). Data were presented as mean ± SD. # P<0.001 vs SO group. Bar=50μm.
Figure2. (A) Immunostaining of WGA and von-Willebrand factor to see glycocalyx or endothelial
surface layer and endothelial cells in the vessel. Arrow indicate disruption of glycocalyx,
but not endothelial cells in day 1 after IRI. (B) eNOS expression after kidney I/R injury.
Bar=50μm.
Upregulation of Heparanase expression after kidney I/R in epithelial and interstitial
cell
To observe the basis of glycocalyx disruption, we quantified heparanase expression in
kidney I/R injury. Kidney I/R injury induced an significant increase of heparanase mRNA and
protein expression (Fig.3 A&B). We did immunostaining of heparanase and revealed that
epithelial cells and interstitial cells as sources of heparanase (Fig.3 C)
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Targeting early event of endothelial injury due to ischemic-reperfusion, in this present
study we observed glycocalyx disruption in the extension phase of I/R injury. Shedding of
glycocalyx is reported in patients undergoing major vascular surgery due to global and re-
gional ischemic (Rehm et al., 2007). Using WGA staining in the vessel, we demonstrated
disruption of glycocalyx in the intra-renal artery, without followed by endothelial cell damage.
We concluded that glycocalyx disruption associated with endothelial dysfunction as shown
by eNOS reduction (Fig.2). Until now, there are no consistent results about endothelial cells
morphology changing during this phase, endothelial dysfunction is believed contributing in
this phase. Actin cytoskeleton and junctional alteration have been already reported occurs in
the vascular endothelial cell using Tie2/GFP following renal ischemic injury in vivo (Sutton et
Figure3. Effects of kidney I/R injury to Heparanase expression. (A) mRNA level of Heparanase in
SO and D1 I/R goup (each n=4-5). (B) Heparanase protein level after kidney I/R injury.
(C) Heparanase was expressed in the renal interstitial space and epithelial cells. Data
was presented as mean ± SD. * P<0.05 vs sham. Bar=50μm.
Figure 4. Effect of 30 minutes ischemia to heparanase, pre-pro ET-1, eNOS and inflammatory
mediators mRNA level. (A) ischemic induced upregulation of heparanase and pre-pro
ET-1 expression and down regulation of eNOS expression. (B) Ischemia also induced
upregulation of inflammatory mediator, such as ICAM-1 but not MCP-1 in MS1 endothelial
cell culture. Data were presented as mean ± SD. * P<0.05 vs control. ± P<0.01 vs
control.
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al., 2002; Sutton et al., 2003). Another studies showed morphologic changing of endothelial
cell including endothelial cell swelling, endothelial cell to cell attachment disruption, and endo-
thelial cell-basement membrane attachment alteration in the renal microvasculature (Brodsky
et al., 2002).
Loss of glomerular endothelial glycocalyx in adriamycin nephropathy model associated
with down regulation of HS and enzymes that play role in synthesis and elongation of
proteoglycan GAG chains (Jeansson et al., 2009). HS loss is also induced by heparanase
production, an endoglycosidase that degrades HS (Rao et al., 2011). In this study, we ob-
served an increase of heparanase expression in extension phase of kidney I/R injury (Fig.3).
The loss of HS is demonstrated in some glomerular diseases in several human and animal
experimental studies, such as passive Heymann Nephritis, anti-GBM Nephritis, puromicyn
induced nephrosis, adriamycin-induced nephrosis, and minimal change diseases. HS loss
in those conditions are correlated with higher expression of glomerular heparanase (van
den Hoven et al., 2007). Treatment of human heparanase and heparinase in cultured
gomerular endothelial cells induces disruption of glycocalyx (Singh et al., 2007). An increase
of heparanase also occurs after focal cerebral ischemic in the mouse brain and correlates
with proliferating endothelial cells undergoing angiogenesis (Li et al., 2012). Heparanase
up-regulation in endothelial cells and macrophages is suggested to play role in reduction of
HS amount in arterial wall and contributes to atherosclerosis (Rao et al., 2011). It seem that
high expression of heparanase after kidney I/R injury leads to endothelial dysfunction with
eNOS reduction and glycocalyx disruption.
We also showed epithelial cell and interstitial cells as sources of heparanase expres-
sion (Fig.3). We assumes that I/R injury contributes to the expression of heparanase in those
cells. Renal epithelial cell has been also shown as a source of heparanase under hypergly-
cemic condition (Maxhimer et al., 2005). Meanwhile, heparanase expression in interstitial
cells might associate with ROS production. Previously, we reported that kidney I/R induced
ROS production that is inhibited by ET-1 deletion from endothelial cells (Arfian et al., 2012).
Our results are consistent with several studies that reported about the role of ROS in mediat-
ing heparanase production, particularly in high glucose condition (Rao et al., 2011), as well
as aldosteron and angiotensin II treatment in glomerulus (van den Hoven et al., 2009). Because
of ROS has different role in the epithelial and interstitial cells after kidney I/R injury (Kim et al.,
2010), it seem that heparanase also regulate those cells differently. For further study, it is
interesting to elucidate role of heparanase in these different cells after kidney I/R injury.
In the kidney diseases, glycocalyx disruption and shedding have been already known
occur in inflammation and ischemic condition (Mulivor & Lipowsky, 2004; Lipowsky et al.,
2011), albuminuria and microvascular permeability (Salmon & Satchell, 2012) and adriamycin
nephropathy (Jeansson et al., 2009). We found here in the culture of endothelial cell in
hypoxic condition demonstrated an increase of inflammation mediator such as ICAM-1. This
might associate with elevation of heparanase and pre-pro ET-1 level. It might show that
hypoxic condition lead to up-regulation of heparanase in endothelial cells. Meanwhile, in the
ischemic and reperfusion the others cells express heparanase, such as epithelial and inter-
stitial cells.
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Taken together HS and glycocalyx loss after kidney I/R might be caused by higher ex-
pression of heparanase. Heparanase that is expressed not only by endothelial cells, but also
by epithelial and interstitial cells might contribute to tubular injury and endothelial dysfunction
in kidney I/R injury.
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